BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 28418927)

  • 41. Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Xia WL; Zhao XH; Guo Y; Hu HT; Cao GS; Li Z; Fan WJ; Xu SJ; Li HL
    Clin Transl Gastroenterol; 2023 May; 14(5):e00581. PubMed ID: 36920551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study.
    Yu JI; Park JW; Park HC; Yoon SM; Lim DH; Lee JH; Lee HC; Kim SW; Kim JH
    Radiother Oncol; 2016 Feb; 118(2):408-15. PubMed ID: 26830695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Hepatocellular Carcinoma with Tumor Thrombus with the Use of Iodine-125 Seed Strand Implantation and Transarterial Chemoembolization: A Propensity-Score Analysis.
    Zhang ZH; Zhang W; Gu JY; Liu QX; Ma JQ; Liu LX; Wang JH; Luo JJ; Yan ZP
    J Vasc Interv Radiol; 2018 Aug; 29(8):1085-1093. PubMed ID: 29754851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.
    Sun JH; Zhou T; Zhu T; Zhang Y; Nie C; Ai J; Zhou G; Zhang A; Dong MJ; Wang WL; Zheng SS
    Biomed Res Int; 2016; 2016():3048261. PubMed ID: 27999793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
    Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
    Leng JJ; Xu YZ; Dong JH
    ANZ J Surg; 2016 Oct; 86(10):816-820. PubMed ID: 25088384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification.
    Niu ZJ; Ma YL; Kang P; Ou SQ; Meng ZB; Li ZK; Qi F; Zhao C
    Med Oncol; 2012 Dec; 29(4):2992-7. PubMed ID: 22200992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial.
    Guo L; Wei X; Feng S; Zhai J; Guo W; Shi J; Lau WY; Meng Y; Cheng S
    Hepatol Int; 2022 Dec; 16(6):1368-1378. PubMed ID: 36271176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.
    Chung GE; Lee JH; Kim HY; Hwang SY; Kim JS; Chung JW; Yoon JH; Lee HS; Kim YJ
    Radiology; 2011 Feb; 258(2):627-34. PubMed ID: 21273524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study.
    Chen J; Lai L; Luo J; Wang H; Li M; Huang M
    BMC Cancer; 2022 Nov; 22(1):1242. PubMed ID: 36451104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Eur Radiol; 2023 Dec; 33(12):8715-8726. PubMed ID: 37436507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis.
    Deng J; Liao Z; Gao J
    Curr Oncol; 2023 Jan; 30(1):1243-1254. PubMed ID: 36661745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
    Shin BS; Park MH; Jeon GS
    Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.
    Alrashidi I; Chu HH; Kim JH; Shim JH; Yoon SM; Kim PH; Gwon DI; Ko HK
    Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1060-1069. PubMed ID: 33745071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation.
    Zhou Q; An Y; Liu T; Liu Z; Li R; Wang C; Zhou F; Liu C; Zhu K
    Int J Hyperthermia; 2022; 39(1):97-107. PubMed ID: 34979845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    Zhang Y; Miao H; Xie W; Jiang S; Song Z; Huang G; Fan W; Wang Y; Li J; Chen Y
    Eur Radiol; 2021 Jan; 31(1):232-243. PubMed ID: 32728770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and Efficacy of Irradiation Stent Placement for Malignant Portal Vein Thrombus Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience.
    Lu J; Guo JH; Zhu HD; Zhu GY; Chen L; Teng GJ
    J Vasc Interv Radiol; 2017 Jun; 28(6):786-794.e3. PubMed ID: 28396192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis--a randomized study.
    Li Q; Wang J; Sun Y; Cui YL; Juzi JT; Li HX; Qian BY; Hao XS
    World J Surg; 2006 Nov; 30(11):2004-11; discussion 2012-3. PubMed ID: 17058027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus.
    Zhang W; Wu L; Chen L; Sun T; Ren Y; Sun B; Zhu L; Han P; Zheng C
    Sci Rep; 2022 Apr; 12(1):5725. PubMed ID: 35388064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.